Terms: = Sarcomas AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Prognosis
20 results:
1. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
2. Histone Methyltransferases G9a/
Souza BK; Freire NH; Monteiro TS; Herlinger AL; Jaeger M; Dalmolin MGS; de Farias CB; Gregianin L; Brunetto AT; Brunetto AL; Thiele CJ; Roesler R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894922
[TBL] [Abstract] [Full Text] [Related]
3. Immune contexture of paediatric cancers.
Thakur MD; Franz CJ; Brennan L; Brouwer-Visser J; Tam R; Korski K; Koeppen H; Ziai J; Babitzki G; Ranchere-Vince D; Vasiljevic A; Dijoud F; Marec-Bérard P; Rochet I; Cannarile MA; Marabelle A
Eur J Cancer; 2022 Jul; 170():179-193. PubMed ID: 35660252
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.
Jansky S; Sharma AK; Körber V; Quintero A; Toprak UH; Wecht EM; Gartlgruber M; Greco A; Chomsky E; Grünewald TGP; Henrich KO; Tanay A; Herrmann C; Höfer T; Westermann F
Nat Genet; 2021 May; 53(5):683-693. PubMed ID: 33767450
[TBL] [Abstract] [Full Text] [Related]
5. Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.
Yuan B; Ji W; Xia H; Li J
Mol Med Rep; 2018 Mar; 17(3):4291-4298. PubMed ID: 29328472
[TBL] [Abstract] [Full Text] [Related]
6. Sphingosine Induces Apoptosis and Down-regulation of
Ahn EH; Lee MB; Seo DJ; Lee J; Kim Y; Gupta K
Anticancer Res; 2018 Jan; 38(1):71-76. PubMed ID: 29277758
[TBL] [Abstract] [Full Text] [Related]
7. Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors.
Schwermer M; Lee S; Köster J; van Maerken T; Stephan H; Eggert A; Morik K; Schulte JH; Schramm A
Oncotarget; 2015 Jun; 6(17):15425-35. PubMed ID: 26029996
[TBL] [Abstract] [Full Text] [Related]
8. Sulforaphane induces apoptosis in rhabdomyosarcoma and restores TRAIL-sensitivity in the aggressive alveolar subtype leading to tumor elimination in mice.
Bergantin E; Quarta C; Nanni C; Fanti S; Pession A; Cantelli-Forti G; Tonelli R; Hrelia P
Cancer Biol Ther; 2014 Sep; 15(9):1219-25. PubMed ID: 24971463
[TBL] [Abstract] [Full Text] [Related]
9. n-myc downstream-regulated gene 1/Cap43 expression promotes cell differentiation of human osteosarcoma cells.
Matsugaki T; Zenmyo M; Hiraoka K; Fukushima N; Shoda T; Komiya S; Ono M; Kuwano M; Nagata K
Oncol Rep; 2010 Sep; 24(3):721-5. PubMed ID: 20664979
[TBL] [Abstract] [Full Text] [Related]
10. [Neonatal tumors].
Costa C; Rocha G; Grilo M; Bianchi R; Sotto Mayor T; Monteiro J; Guimarães H
Acta Med Port; 2010; 23(3):405-12. PubMed ID: 20654259
[TBL] [Abstract] [Full Text] [Related]
11. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
[TBL] [Abstract] [Full Text] [Related]
12. Fine needle biopsy and genetics, two allied weapons in the diagnosis, prognosis, and target therapeutics of solid pediatric tumors.
Barroca H
Diagn Cytopathol; 2008 Sep; 36(9):678-84. PubMed ID: 18677757
[TBL] [Abstract] [Full Text] [Related]
13. Relationship between mycn copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype.
Williamson D; Lu YJ; Gordon T; Sciot R; Kelsey A; Fisher C; Poremba C; Anderson J; Pritchard-Jones K; Shipley J
J Clin Oncol; 2005 Feb; 23(4):880-8. PubMed ID: 15681534
[TBL] [Abstract] [Full Text] [Related]
14. Use of the ornithine decarboxylase promoter to achieve n-myc-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11.
Pawlik CA; Iyengar RV; Krull EJ; Mason SE; Khanna R; Harris LC; Potter PM; Danks MK; Guichard SM
Mol Ther; 2000 May; 1(5 Pt 1):457-63. PubMed ID: 10933967
[TBL] [Abstract] [Full Text] [Related]
15. Risk-based management: current concepts of treating malignant solid tumors of childhood.
Grosfeld JL
J Am Coll Surg; 1999 Oct; 189(4):407-25. PubMed ID: 10509467
[TBL] [Abstract] [Full Text] [Related]
16. Cytogenetic and immunohistochemical analysis of an adult anaplastic neuroblastoma.
Cowan JM; Dayal Y; Schwaitzberg S; Tischler AS
Am J Surg Pathol; 1997 Aug; 21(8):957-63. PubMed ID: 9255260
[TBL] [Abstract] [Full Text] [Related]
17. [Amplification of oncogenes in solid tumors in children].
Mares J; Lesková V; Sedlácek Z; Maríková T; Bocek P; Kodet R; Goetz P
Cas Lek Cesk; 1996 Jul; 135(15):493-6. PubMed ID: 8925552
[TBL] [Abstract] [Full Text] [Related]
18. New entities, concepts, and questions in childhood tumor pathology.
Harms D
Gen Diagn Pathol; 1995 May; 141(1):1-14. PubMed ID: 8542501
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistology, cytogenetics, and molecular studies of small round cell tumors of childhood. A review.
Winters JL; Geil JD; O'Connor WN
Ann Clin Lab Sci; 1995; 25(1):66-78. PubMed ID: 7762971
[TBL] [Abstract] [Full Text] [Related]
20. [Cytogenetics in pediatric solid tumors].
Kaneko Y
Rinsho Byori; 1990 Sep; 38(9):1047-52. PubMed ID: 2172598
[TBL] [Abstract] [Full Text] [Related]
